$19.08
0.08[0.42%]
At close: May 17
$19.08
0[0.00%]
After Hours: 4:00PM EDT
Marex Group
(NASDAQ:MRX)Latest News for Marex Group Stock (NASDAQ:MRX)
Marex Group Stock (NASDAQ: MRX)
Categories: All
Thursday, May 16, 2024
Thursday, April 25, 2024
- Marex Group Shares Open For Trade At $19.50/Share; IPO Priced At $19/Share On 15.385M SharesBenzinga Newsdesk - Apr 25, 2024, 12:08PM
- Marex Group IPO Indicating $19.50/Share On 1,028,839 Shares; IPO Priced At $19/Share On 15.385M SharesBenzinga Newsdesk - Apr 25, 2024, 11:56AM
- Marex Group IPO Indicating $20/Share On 652,128 Shares; IPO Priced At $19/Share On 15.385M SharesBenzinga Newsdesk - Apr 25, 2024, 11:26AM
Wednesday, April 24, 2024
Sunday, April 21, 2024
Monday, April 15, 2024
Wednesday, December 05, 2012
Friday, November 16, 2012
Wednesday, November 14, 2012
Friday, November 09, 2012
Monday, October 08, 2012
Wednesday, October 03, 2012
Tuesday, September 25, 2012
Monday, September 24, 2012
Thursday, September 13, 2012
Wednesday, September 05, 2012
- Barclays Maintains Medicis Pharmaceutical at Equal-weight, Raises PT from $35 to $44Benzinga - Sep 5, 2012, 12:19PM
- UPDATE: Stifel Nicolaus Downgrades Medicis Pharmaceutical to HoldBenzinga - Sep 5, 2012, 10:45AM
- UPDATE: Goldman Sachs Downgrades Medicis Pharmaceutical to Neutral, Raises PTBenzinga - Sep 5, 2012, 9:55AM
- Stifel Nicolaus Downgrades Medicis Pharmaceutical from Buy to Hold, Removes PTBenzinga - Sep 5, 2012, 8:04AM
- Goldman Sachs Downgrades Medicis Pharmaceutical from Buy to Neutral, Raises PT from $42 to $44Benzinga - Sep 5, 2012, 7:29AM
Tuesday, September 04, 2012
- Benzinga's M&A Chatter for Tuesday September 4, 2012Benzinga - Sep 4, 2012, 5:35PM
- Valeant Soars on Medicis BuyoutBenzinga - Sep 4, 2012, 1:40PM
- Piper Jaffray Downgrades Medicis Pharmaceutical from Overweight to Neutral, Raises PT from $41 to $44Benzinga - Sep 4, 2012, 11:00AM
- Canaccord Maintains Medicis Pharmaceutical at Hold, Raises PT to $44Benzinga - Sep 4, 2012, 10:59AM
- Benzinga's Top Pre-Market GainersBenzinga - Sep 4, 2012, 8:07AM
- Benzinga Market Primer, Tuesday September 4Benzinga - Sep 4, 2012, 7:59AM
- Medicis Pharmaceutical Bid 36% Higher Pre-Market on Valeant Acquisition for $44.00 Per Share In Cash Announced MondayBenzinga - Sep 4, 2012, 7:08AM
- Cantor Fitzgerald Maintains Medicis Pharmaceutical at Hold, Raises PT from $36 to $44Benzinga - Sep 4, 2012, 6:49AM
- Credit Suisse Upgrades Medicis Pharmaceutical from Underperform to Neutral, Raises PT from $33 to $44Benzinga - Sep 4, 2012, 6:41AM
- US Stock Futures Up; ISM Manufacturing Data In FocusBenzinga - Sep 4, 2012, 6:31AM
- Top 4 Small-Cap Stocks In The Drugs-Generic Industry With The Highest ROABenzinga - Sep 4, 2012, 4:03AM
- Stocks To Watch For September 4, 2012Benzinga - Sep 4, 2012, 3:58AM
Monday, September 03, 2012
Thursday, August 09, 2012
- Bank of America Maintains Medicis Pharmaceutical at Neutral, Lowers PO from $40 to $38Benzinga - Aug 9, 2012, 7:59AM
- Goldman Sachs Maintains Medicis Pharmaceutical at Buy, Lowers PT from $45 to $42Benzinga - Aug 9, 2012, 7:16AM
- Piper Jaffray Maintains Medicis Pharmaceutical at Overweight, Lowers PT from $45 to $41Benzinga - Aug 9, 2012, 6:43AM
- Deutsche Bank Maintains Medicis Pharmaceutical at Buy, Lowers PT from $44 to $37Benzinga - Aug 9, 2012, 6:26AM